icon-folder.gif   Conference Reports for NATAP  
 
  AASLD
The Liver Meeting
Boston MA
November 2016
Back grey_arrow_rt.gif
 
 
 
Assessment of risk of acute kidney injury associated with exposure to
sofosbuvir-containing HCV treatment regimens and HCV infection

 
 
  Reported by Jules Levin
AASLD 2016 Nov 11-15 Boston, MA
 
L Telep, A Brown, DM Brainard, AP Chokkalingam
Gilead Sciences, Inc., Foster City, CA, United States

HIV1

HIV2

HIV3

HIV4